Economic evaluation of a single-pill triple antihypertensive therapy with valsartan, amlodipine, and hydrochlorothiazide against its dual components
Crossref DOI link: https://doi.org/10.1186/s12962-015-0036-x
Published Online: 2015-06-09
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Stafylas, Panagiotis
Kourlaba, Georgia
Hatzikou, Magda
Georgiopoulos, Dimitrios
Sarafidis, Pantelis
Maniadakis, Nikolaos
License valid from 2015-06-09